These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21368431)

  • 1. Recombinant-adeno-associated viral vector-mediated gene therapy for cardiovascular diseases.
    Zhang M; Yuan H; Huang Z; Hu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):178-84. PubMed ID: 21368431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the use of adeno-associated viral vectors for gene therapy.
    Büning H; Braun-Falco M; Hallek M
    Cells Tissues Organs; 2004; 177(3):139-50. PubMed ID: 15388988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro study on two kind of recombinant adeno-associated virus-mediated transfection efficiency with enhanced green fluorescent protein into rats osteoblasts].
    Jiang X; Yang CY; Mao M; Liu QQ; Wang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 41(2):203-7. PubMed ID: 20506635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries.
    Wang T; Li H; Zhao C; Chen C; Li J; Chao J; Chao L; Xiao X; Wang DW
    Gene Ther; 2004 Sep; 11(17):1342-50. PubMed ID: 15175642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated viral vectors for gene transfer and gene therapy.
    Büeler H
    Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of recombinant adeno-associated virus for skeletal gene therapy.
    Dai J; Rabie AB
    Orthod Craniofac Res; 2007 Feb; 10(1):1-14. PubMed ID: 17284242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in adeno-associated virus vector technology.
    Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
    J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing gene delivery vectors for cardiovascular gene therapy.
    Baker AH
    Prog Biophys Mol Biol; 2004; 84(2-3):279-99. PubMed ID: 14769440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthopaedic gene therapy using recombinant adeno-associated virus vectors.
    Ke J; Zheng LW; Cheung LK
    Arch Oral Biol; 2011 Jul; 56(7):619-28. PubMed ID: 21354554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trends in development of self-complementary adeno-associated virus vector].
    Lü Y; Wang Q; Xiao W; Diao Y; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):658-64. PubMed ID: 19670632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated viral vectors: background and technical aspects.
    Snoeck HW; Tao W; Klotman ME
    Exp Nephrol; 1997; 5(6):514-20. PubMed ID: 9438181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor targeting of adeno-associated virus vectors.
    Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
    Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvovirus-based vectors for human gene therapy.
    Srivastava A
    Blood Cells; 1994; 20(2-3):531-6; discussion 536-8. PubMed ID: 7538355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific integration of a transgene mediated by a hybrid adenovirus/adeno-associated virus vector using the Cre/loxP-expression-switching system.
    Ueno T; Matsumura H; Tanaka K; Iwasaki T; Ueno M; Fujinaga K; Asada K; Kato I
    Biochem Biophys Res Commun; 2000 Jul; 273(2):473-8. PubMed ID: 10873630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.
    Blankinship MJ; Gregorevic P; Chamberlain JS
    Mol Ther; 2006 Feb; 13(2):241-9. PubMed ID: 16361117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
    During MJ; Leone P
    Clin Neurosci; 1995-1996; 3(5):292-300. PubMed ID: 8914796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus vectors for gene therapy.
    Flotte TR; Carter BJ
    Gene Ther; 1995 Aug; 2(6):357-62. PubMed ID: 7584109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gene transfer using adeno-associated virus (AAV) vectors].
    Shimada T
    Nihon Rinsho; 1997 Aug; 55(8):2156-9. PubMed ID: 9284438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human endostatin antiangiogenic gene therapy mediated by recombinant adeno-associated virus vector in nude mouse with endometriosis].
    Sun JJ; Yin LR; Mi RR; Ma HD; Guo SJ; Shi Y; Gu YJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):45-50. PubMed ID: 20367926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.